389 related articles for article (PubMed ID: 34435402)
1. Bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by secreting thrombospondin-2.
Shi H; Qi C; Meng L; Yao H; Jiang C; Fan M; Zhang Q; Hou X; Lin R
Cell Prolif; 2021 Oct; 54(10):e13114. PubMed ID: 34435402
[TBL] [Abstract][Full Text] [Related]
2. THBS4/integrin α2 axis mediates BM-MSCs to promote angiogenesis in gastric cancer associated with chronic
He L; Wang W; Shi H; Jiang C; Yao H; Zhang Y; Qian W; Lin R
Aging (Albany NY); 2021 Aug; 13(15):19375-19396. PubMed ID: 34390328
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
4. Native and bone marrow-derived cell mosaicism in gastric carcinoma in H. pylori-infected p27-deficient mice.
Zhang S; Kim W; Pham TT; Rogers AB; Houghton JM; Moss SF
Oncotarget; 2016 Oct; 7(43):69136-69148. PubMed ID: 27655701
[TBL] [Abstract][Full Text] [Related]
5. Microvesicles from bone marrow-derived mesenchymal stem cells promote Helicobacter pylori-associated gastric cancer progression by transferring thrombospondin-2.
Qi C; Shi H; Fan M; Chen W; Yao H; Jiang C; Meng L; Pang S; Lin R
Cell Commun Signal; 2023 Oct; 21(1):274. PubMed ID: 37798762
[TBL] [Abstract][Full Text] [Related]
6. Gastritis promotes an activated bone marrow-derived mesenchymal stem cell with a phenotype reminiscent of a cancer-promoting cell.
Donnelly JM; Engevik AC; Engevik M; Schumacher MA; Xiao C; Yang L; Worrell RT; Zavros Y
Dig Dis Sci; 2014 Mar; 59(3):569-82. PubMed ID: 24202649
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori infection recruits bone marrow-derived cells that participate in gastric preneoplasia in mice.
Varon C; Dubus P; Mazurier F; Asencio C; Chambonnier L; Ferrand J; Giese A; Senant-Dugot N; Carlotti M; Mégraud F
Gastroenterology; 2012 Feb; 142(2):281-91. PubMed ID: 22062361
[TBL] [Abstract][Full Text] [Related]
8. H. pylori infection-induced MSC differentiation into CAFs promotes epithelial-mesenchymal transition in gastric epithelial cells.
Zhang Q; Wang M; Huang F; Yang T; Cai J; Zhang X; Zhu W; Qian H; Xu W
Int J Mol Med; 2013 Dec; 32(6):1465-73. PubMed ID: 24145921
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer.
Shen J; Zhai J; You Q; Zhang G; He M; Yao X; Shen L
Oncogene; 2020 Apr; 39(14):2961-2974. PubMed ID: 32034307
[TBL] [Abstract][Full Text] [Related]
10. Involvement of epithelial-mesenchymal transition-inducing transcription factors in the mechanism of Helicobacter pylori-induced fibroblasts activation.
Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzalka M; Brzozowski T; Ptak-Belowska A
J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 31889044
[TBL] [Abstract][Full Text] [Related]
11. Deletion of IQGAP1 promotes Helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro.
Bessède E; Molina S; Acuña-Amador L; Dubus P; Staedel C; Chambonnier L; Buissonnière A; Sifré E; Giese A; Bénéjat L; Rousseau B; Costet P; Sacks DB; Mégraud F; Varon C
Oncotarget; 2016 Dec; 7(49):80688-80699. PubMed ID: 27729612
[TBL] [Abstract][Full Text] [Related]
12. Chronic CagA-positive Helicobacter pylori infection with MNNG stimulation synergistically induces mesenchymal and cancer stem cell-like properties in gastric mucosal epithelial cells.
Lin L; Wei H; Yi J; Xie B; Chen J; Zhou C; Wang L; Yang Y
J Cell Biochem; 2019 Oct; 120(10):17635-17649. PubMed ID: 31209915
[TBL] [Abstract][Full Text] [Related]
13. K-ras mutation targeted to gastric tissue progenitor cells results in chronic inflammation, an altered microenvironment, and progression to intraepithelial neoplasia.
Okumura T; Ericksen RE; Takaishi S; Wang SS; Dubeykovskiy Z; Shibata W; Betz KS; Muthupalani S; Rogers AB; Fox JG; Rustgi AK; Wang TC
Cancer Res; 2010 Nov; 70(21):8435-45. PubMed ID: 20959488
[TBL] [Abstract][Full Text] [Related]
14. Gamma-glutamyltransferase of Helicobacter pylori alters the proliferation, migration, and pluripotency of mesenchymal stem cells by affecting metabolism and methylation status.
Wang Z; Wang W; Shi H; Meng L; Jiang X; Pang S; Fan M; Lin R
J Microbiol; 2022 Jun; 60(6):627-639. PubMed ID: 35437622
[TBL] [Abstract][Full Text] [Related]
15. Role of Helicobacter pylori infection in cancer-associated fibroblast-induced epithelial-mesenchymal transition in vitro.
Krzysiek-Maczka G; Targosz A; Szczyrk U; Strzałka M; Sliwowski Z; Brzozowski T; Czyz J; Ptak-Belowska A
Helicobacter; 2018 Dec; 23(6):e12538. PubMed ID: 30246423
[TBL] [Abstract][Full Text] [Related]
16. Identification of a bone marrow-derived mesenchymal progenitor cell subset that can contribute to the gastric epithelium.
Okumura T; Wang SS; Takaishi S; Tu SP; Ng V; Ericksen RE; Rustgi AK; Wang TC
Lab Invest; 2009 Dec; 89(12):1410-22. PubMed ID: 19841619
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori CagA promotes the malignant transformation of gastric mucosal epithelial cells through the dysregulation of the miR-155/KLF4 signaling pathway.
Ou Y; Ren H; Zhao R; Song L; Liu Z; Xu W; Liu Y; Wang S
Mol Carcinog; 2019 Aug; 58(8):1427-1437. PubMed ID: 31162747
[TBL] [Abstract][Full Text] [Related]
18. Helicobacter pylori infection and stem cells at the origin of gastric cancer.
Bessède E; Dubus P; Mégraud F; Varon C
Oncogene; 2015 May; 34(20):2547-55. PubMed ID: 25043305
[TBL] [Abstract][Full Text] [Related]
19. Chemoprevention of gastric cancer by Helicobacter pylori eradication and its underlying mechanism.
Kim N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1287-1295. PubMed ID: 30828872
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori Depletes Cholesterol in Gastric Glands to Prevent Interferon Gamma Signaling and Escape the Inflammatory Response.
Morey P; Pfannkuch L; Pang E; Boccellato F; Sigal M; Imai-Matsushima A; Dyer V; Koch M; Mollenkopf HJ; Schlaermann P; Meyer TF
Gastroenterology; 2018 Apr; 154(5):1391-1404.e9. PubMed ID: 29273450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
